A Phase 1b/2, Open-label, Multicenter Study of Novel Oncology Therapies in Combination with Chemotherapy and Bevacizumab as First-line Therapy in Metastatic Microsatellite-stable Colorectal Cancer

Project: Research

AcronymCOLUMBIA-1
StatusActive
Effective start/end date26/09/1925/09/24

Keywords

  • clinical trial
  • treatment efficacy
  • phase 1 and 2 study
  • colorectal cancer